g


Register Interest

Ensysce Biosciences Inc.

Ensysce, a clinical-stage company, is using its proprietary TAAP and MPAR™ platforms to develop safer prescription drugs. Its lead drug candidate, PF614, will create a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdose. Our mission is to provide safer options to treat severe pain, reducing the human and economic costs caused by drug abuse